Hudson, Wis. – October 27, 2025: CIRANDA announced a strategic partnership with Incredo to deliver transformational, clean-label sugar solutions to food and ingredient manufacturers. The joint effort aims to enable brands to reformulate bakery goods, bars, snacks and confectioneries with significantly reduced sugar content using Incredo’s patented cane sugar-based technology.
Science Significance
The partnership centres on a novel sugar technology that allows manufacturers to cut sugar content by up to 70%, while maintaining the taste and texture consumers expect. Incredo’s invention uses real cane sugar and a patented process (without artificial sweeteners, sugar alcohols or high-intensity sweeteners) to deliver full-flavour profiles with fewer grams of sugar. This innovation reflects advances in ingredient science, food-formulation technology and consumer-driven nutrition research, marking a significant shift toward healthier food design.
Regulatory Significance
In the evolving regulatory landscape around sugar reduction, nutrition labelling and clean-label claims, this partnership positions both companies ahead of future compliance demands. The technology allows label listing simply as “cane sugar” or “cane sugar, protein,” reducing complexity for manufacturers. As authorities globally increasingly scrutinise sugar content, nutrient claims and ingredient simplicity, the collaboration helps brands navigate food-safety, labelling and health-claim regulations more effectively.
Business Significance
Advertisement
From a commercial standpoint, the alliance gives CIRANDA access to Incredo’s proprietary platform and extends its ingredient-portfolio compellingly into the high-growth sugar-reduction market. For Incredo, CIRANDA’s branded distribution and manufacturing network open broad scale-up and market access in North America. Together, they tap into rising consumer demand for better-for-you indulgent foods, creating new revenue streams and positioning both companies as innovators in the food-tech ingredient space.
Patients’ Significance
While not clinical in the pharmaceutical sense, the impact on consumers (patients) is meaningful: reducing sugar consumption can contribute to lower risk of metabolic diseases, obesity and dental issues. For individuals seeking better-for-you indulgences without sacrificing taste, this innovation supports healthier dietary choices. Food manufacturers adopting these solutions may help millions of consumers enjoy treats with fewer health-risks.
Policy Significance
This partnership aligns with global policy trends emphasising sugar reduction, clean-label transparency and improved nutrition. Governments and regulatory bodies are increasingly implementing strategies and guidelines to curb excess sugar consumption and promote public health. The CIRANDA-Incredo collaboration therefore supports policy objectives around nutrition reformulation, ingredient transparency and healthier food ecosystems.
The CIRANDA and Incredo partnership marks a significant leap in food-innovation, combining deep ingredient expertise with patented sugar-reduction technology to meet both consumer and regulatory demands. While not directly connected to pharmaceutical drug development, this collaboration is timely and influential within the food-health domain — offering manufacturers a reliable clean-label solution and consumers a healthier alternative without compromise.
Source: CIRANDA press release
